Admune Therapeutics: Swiss drug giant to acquire Massachusetts research company
Novartis to buy Danvers-based Admume Therapeutics for its engineered protein said to boost the immune system to fight undetected cancer cells.
Read full article »
President & CEO
Sergio Finkielsztein
Admune discovers, develops and commercializes cytokine cancer therapy drugs for treating cancer patients.
Read more